Deutsch (DE-CH-AT)English (United Kingdom)

News

Guidelines confirm: less impotence and incontinence after seed implantations compared to surgery

  • PDF
  • Print
  • E-mail

What has already been evidenced in numerous international studies1, has now been confirmed by leading experts: prostate cancer patients, who receive brachytherapy (internal beam radiation), suffer significantly less from incompetence after the treatment. This is also true for incontinence, which is with a 0,3 to 3 percent occurrence disappearingly small compared to an occurrence of 50 percent in cases in which prostate carcinoma was treated by surgery2. Additionally, Incontinence actually occurs only after previously performed transurethral prostate resection (TURP).

Read more...

 

More side effects after robot-assisted surgery

  • PDF
  • Print
  • E-mail
The modern robot-assisted surgery, which was unbiased accepted as a treatment option without distress for the patient, proves to have more side effects than has been advocated so far. Thus, the most recent cohort study1 published in the Journal of American Medical Association - JAMA, shows that robotic surgery can increase the rate of complications, such as impotence and incontinence. In spite of the less invasive technique, these complications are even more pronounced after robotic-assisted surgery than after standard surgical therapies for localized prostate cancer. The results of the study show that the rate of incontinence after a robotic surgery increase to 24 percent and the erectile dysfunction increases to 29 percent
 

Prostate Carcinoma: Just wait and see, and not do anything?

  • PDF
  • Print
  • E-mail
Thanks to improved early detection methods, prostate carcinoma are more often discovered at an early stage, and especially in Germany this still leads to radical surgical procedures. At the same time, many of these tumors would never cause any problems, let alone cause death. In the battle of this “overtreatment“, the defensive strategies such as the „active surveillance“ or the low-risk brachytherapy with few side effects become very essential therapies.
 

Implementing the prostate cancer guidelines

  • PDF
  • Print
  • E-mail
None of the developments in medicine is beneficial, if it does not reach the patient. For this reason, the Professional Association of the German Urologists (Berufsverband der Deutschen Urologen e.V., BDU) wants to translate the new S3 Guidelines for the treatment of the prostate carcinoma into practice. In a statewide initiative furthering education, the currently available knowledge of early detection, diagnosis, and therapies is to be conveyed to all urologists in German. According to the President of the Association, Dr. Martin Bloch, the stated objective of the BDU is that patients profit as quickly as possible from the new developments, and receive “beneficial treatment in accordance with the guidelines”.
 

HIFU and Cryotherapy are currently not justified

  • PDF
  • Print
  • E-mail
HIFU (high intensity focused ultrasound), as well as cryotherapy prove not to be adequate alternatives for the treatment of localized prostate carcinoma. These are the latest findings in the new Prostate Carcinoma Guideline that was recently introduced by the German Society for Urology (DGU). The consensus of the experts is that to date there are no study results that justify these two therapies.
 

8th Uro-oncologic Update Symposium on Prostate Cancer on 1.3.2008 in Cologne

  • PDF
  • Print
  • E-mail
On 01. March 2008 from 9.00 am to 13.00 pm the West Germans prostate center hosts the Uro-oncologic Update Symposium for the eighth time at the Maternushaus in Cologne. Together with renowned experts from Europe and the United States, we invite you warmly to discuss the latest developments in the diagnosis and therapy of prostate cancer. The focus is on the possibilities and limits of current options.

Read more...

 

Page 2 of 2